Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Review Article

Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management

Author(s): Salar Pashangzadeh, Reza Yazdani*, Farzad Nazari, Gholamreza Azizi, Hassan Abolhassani and Asghar Aghamohammadi*

Volume 20, Issue 9, 2020

Page: [1434 - 1447] Pages: 14

DOI: 10.2174/1871530320666200508114349

Price: $65

Abstract

Agammaglobulinemia is a type of primary antibody deficiencies, characterized by severe reduction in serum level of all types of immunoglobulins level and absence of B cells in the peripheral blood. X-linked and various autosomal recessive/dominant mutations have been identified underlying the pathogenesis of this disorder. Affected patients present a broad range of clinical manifestations, including respiratory infections, gastrointestinal complications, Enterovirus infections, autoimmunity, and malignancies. This disease can be controlled by different therapeutic strategies. In this review, we describe different aspects of agammaglobulinemia such as epidemiology, pathogenesis, clinical phenotype, diagnosis, management, and prognosis of congenital agammaglobulinemia.

Keywords: Primary immunodeficiency, agammaglobulinemia, epidemiology, pathogenesis, clinical phenotype, diagnosis, management, prognosis.

« Previous Next »
Graphical Abstract

[1]
Azizi, G.; Yazdani, R. Predominantly antibody deficiencies. Immunology and Genetics Journal, 2018, 1(2), 52-80.
[http://dx.doi.org/10.22034/IGJ.2018.80253]]
[2]
Conley, M.E.; Dobbs, A.K.; Farmer, D.M.; Kilic, S.; Paris, K.; Grigoriadou, S.; Coustan-Smith, E.; Howard, V.; Campana, D. Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol., 2009, 27, 199-227.
[http://dx.doi.org/10.1146/annurev.immunol.021908.132649 ] [PMID: 19302039]
[3]
Lopez Granados, E.; Porpiglia, A.S.; Hogan, M.B.; Matamoros, N.; Krasovec, S.; Pignata, C.; Smith, C.I.; Hammarstrom, L.; Bjorkander, J.; Belohradsky, B.H.; Casariego, G.F.; Garcia Rodriguez, M.C.; Conley, M.E. Clinical and molecular analysis of patients with defects in micro heavy chain gene. J. Clin. Invest., 2002, 110(7), 1029-1035.
[http://dx.doi.org/10.1172/JCI0215658 ] [PMID: 12370281]
[4]
Yel, L.; Minegishi, Y.; Coustan-Smith, E.; Buckley, R.H.; Trübel, H.; Pachman, L.M.; Kitchingman, G.R.; Campana, D.; Rohrer, J.; Conley, M.E. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N. Engl. J. Med., 1996, 335(20), 1486-1493.
[http://dx.doi.org/10.1056/NEJM199611143352003 ] [PMID: 8890099]
[5]
Minegishi, Y.; Rohrer, J.; Coustan-Smith, E.; Lederman, H.M.; Pappu, R.; Campana, D.; Chan, A.C.; Conley, M.E. An essential role for BLNK in human B cell development. Science, 1999, 286(5446), 1954-1957.
[http://dx.doi.org/10.1126/science.286.5446.1954 ] [PMID: 10583958]
[6]
Minegishi, Y.; Coustan-Smith, E.; Wang, Y.H.; Cooper, M.D.; Campana, D.; Conley, M.E. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J. Exp. Med., 1998, 187(1), 71-77.
[http://dx.doi.org/10.1084/jem.187.1.71 ] [PMID: 9419212]
[7]
Sawada, A.; Takihara, Y.; Kim, J.Y.; Matsuda-Hashii, Y.; Tokimasa, S.; Fujisaki, H.; Kubota, K.; Endo, H.; Onodera, T.; Ohta, H.; Ozono, K.; Hara, J. A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J. Clin. Invest., 2003, 112(11), 1707-1713.
[http://dx.doi.org/10.1172/JCI18937 ] [PMID: 14660746]
[8]
Conley, M.E.; Dobbs, A.K.; Quintana, A.M.; Bosompem, A.; Wang, Y.D.; Coustan-Smith, E.; Smith, A.M.; Perez, E.E.; Murray, P.J. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J. Exp. Med., 2012, 209(3), 463-470.
[http://dx.doi.org/10.1084/jem.20112533 ] [PMID: 22351933]
[9]
Abolhassani, H; Parvaneh, N; Rezaei, N; Hammarström, L; Aghamohammadi, A. Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol., 2014, 24(1), 6-22. quiz 2 p following
[10]
Dobbs, A.K.; Yang, T.; Farmer, D.; Kager, L.; Parolini, O.; Conley, M.E. Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J. Immunol., 2007, 179(4), 2055-2059.
[http://dx.doi.org/10.4049/jimmunol.179.4.2055 ] [PMID: 17675462]
[11]
Ferrari, S.; Lougaris, V.; Caraffi, S.; Zuntini, R.; Yang, J.; Soresina, A.; Meini, A.; Cazzola, G.; Rossi, C.; Reth, M.; Plebani, A. Mutations of the Igbeta gene cause agammaglobulinemia in man. J. Exp. Med., 2007, 204(9), 2047-2051.
[http://dx.doi.org/10.1084/jem.20070264 ] [PMID: 17709424]
[12]
Khalili, A.; Plebani, A.; Vitali, M.; Abolhassani, H.; Lougaris, V.; Mirminachi, B.; Rezaei, N.; Aghamohammadi, A. Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a. J. Clin. Immunol., 2014, 34(2), 138-141.
[http://dx.doi.org/10.1007/s10875-014-9989-3 ] [PMID: 24481606]
[13]
Minegishi, Y.; Coustan-Smith, E.; Rapalus, L.; Ersoy, F.; Campana, D.; Conley, M.E. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J. Clin. Invest., 1999, 104(8), 1115-1121.
[http://dx.doi.org/10.1172/JCI7696 ] [PMID: 10525050]
[14]
Wang, Y.; Kanegane, H.; Sanal, O.; Tezcan, I.; Ersoy, F.; Futatani, T.; Miyawaki, T. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am. J. Med. Genet., 2002, 108(4), 333-336.
[http://dx.doi.org/10.1002/ajmg.10296 ] [PMID: 11920841]
[15]
Broderick, L.; Yost, S.; Li, D.; McGeough, M.D.; Booshehri, L.M.; Guaderrama, M.; Brydges, S.D.; Kucharova, K.; Patel, N.C.; Harr, M.; Hakonarson, H.; Zackai, E.; Cowell, I.G.; Austin, C.A.; Hügle, B.; Gebauer, C.; Zhang, J.; Xu, X.; Wang, J.; Croker, B.A.; Frazer, K.A.; Putnam, C.D.; Hoffman, H.M. Mutations in topoisomerase IIβ result in a B cell immunodeficiency. Nat. Commun., 2019, 10(1), 3644.
[http://dx.doi.org/10.1038/s41467-019-11570-6 ] [PMID: 31409799]
[16]
Anzilotti, C.; Swan, D.J.; Boisson, B.; Deobagkar-Lele, M.; Oliveira, C.; Chabosseau, P.; Engelhardt, K.R.; Xu, X.; Chen, R.; Alvarez, L.; Berlinguer-Palmini, R.; Bull, K.R.; Cawthorne, E.; Cribbs, A.P.; Crockford, T.L.; Dang, T.S.; Fearn, A.; Fenech, E.J.; de Jong, S.J.; Lagerholm, B.C.; Ma, C.S.; Sims, D.; van den Berg, B.; Xu, Y.; Cant, A.J.; Kleiner, G.; Leahy, T.R.; de la Morena, M.T.; Puck, J.M.; Shapiro, R.S.; van der Burg, M.; Chapman, J.R.; Christianson, J.C.; Davies, B.; McGrath, J.A.; Przyborski, S.; Santibanez Koref, M.; Tangye, S.G.; Werner, A.; Rutter, G.A.; Padilla-Parra, S.; Casanova, J.L.; Cornall, R.J.; Conley, M.E.; Hambleton, S. An essential role for the Zn2+ transporter ZIP7 in B cell development. Nat. Immunol., 2019, 20(3), 350-361.
[http://dx.doi.org/10.1038/s41590-018-0295-8 ] [PMID: 30718914]
[17]
Boisson, B.; Wang, Y.D.; Bosompem, A.; Ma, C.S.; Lim, A.; Kochetkov, T.; Tangye, S.G.; Casanova, J.L.; Conley, M.E. A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells. J. Clin. Invest., 2013, 123(11), 4781-4785.
[http://dx.doi.org/10.1172/JCI71927 ] [PMID: 24216514]
[18]
Conley, M.E.; Broides, A.; Hernandez-Trujillo, V.; Howard, V.; Kanegane, H.; Miyawaki, T.; Shurtleff, S.A. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev., 2005, 203, 216-234.
[http://dx.doi.org/10.1111/j.0105-2896.2005.00233.x ] [PMID: 15661032]
[19]
Suri, D.; Rawat, A.; Singh, S. X-linked Agammaglobulinemia. Indian J. Pediatr., 2016, 83(4), 331-337.
[http://dx.doi.org/10.1007/s12098-015-2024-8 ] [PMID: 26909497]
[20]
Azizi, G.; Abolhassani, H.; Asgardoon, M.H.; Rahnavard, J.; Dizaji, M.Z.; Yazdani, R.; Mohammadi, J.; Aghamohammadi, A. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr. Metab. Immune Disord. Drug Targets, 2016, 16(2), 80-88.
[http://dx.doi.org/10.2174/1871530316666160724214418 ] [PMID: 27456825]
[21]
Modell, V.; Knaus, M.; Modell, F.; Roifman, C.; Orange, J.; Notarangelo, L.D. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol. Res., 2014, 60(1), 132-144.
[http://dx.doi.org/10.1007/s12026-014-8498-z ] [PMID: 24668296]
[22]
Rezaei, N.; Abolhassani, H.; Kasraian, A.; Mohammadinejad, P.; Sadeghi, B.; Aghamohammadi, A. Family study of pediatric patients with primary antibody deficiencies. Iran. J. Allergy Asthma Immunol., 2013, 12(4), 377-382.
[PMID: 23996714]
[23]
Mohamed, A.J.; Nore, B.F.; Christensson, B.; Smith, C.I. Signalling of Bruton’s tyrosine kinase. Btk. Scand. J. Immunol., 1999, 49(2), 113-118.
[http://dx.doi.org/10.1046/j.1365-3083.1999.00504.x ] [PMID: 10075013]
[24]
Bruton, O.C. Agammaglobulinemia. Pediatrics, 1952, 9(6), 722-728.
[PMID: 14929630]
[25]
Tsukada, S.; Saffran, D.C.; Rawlings, D.J.; Parolini, O.; Allen, R.C.; Klisak, I.; Sparkes, R.S.; Kubagawa, H.; Mohandas, T.; Quan, S. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell, 1993, 72(2), 279-290.
[http://dx.doi.org/10.1016/0092-8674(93)90667-F ] [PMID: 8425221]
[26]
Vetrie, D.; Vorechovský, I.; Sideras, P.; Holland, J.; Davies, A.; Flinter, F.; Hammarström, L.; Kinnon, C.; Levinsky, R.; Bobrow, M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature, 1993, 361(6409), 226-233.
[http://dx.doi.org/10.1038/361226a0 ] [PMID: 8380905]
[27]
Smith, T.; Cunningham-Rundles, C. Primary B-cell immunodeficiencies. Hum. Immunol., 2019, 80(6), 351-362.
[http://dx.doi.org/10.1016/j.humimm.2018.10.015 ] [PMID: 30359632]
[28]
Plebani, A.; Soresina, A.; Rondelli, R.; Amato, G.M.; Azzari, C.; Cardinale, F.; Cazzola, G.; Consolini, R.; De Mattia, D.; Dell’Erba, G.; Duse, M.; Fiorini, M.; Martino, S.; Martire, B.; Masi, M.; Monafo, V.; Moschese, V.; Notarangelo, L.D.; Orlandi, P.; Panei, P.; Pession, A.; Pietrogrande, M.C.; Pignata, C.; Quinti, I.; Ragno, V.; Rossi, P.; Sciotto, A.; Stabile, A. Italian Pediatric Group for XLA-AIEOP. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol., 2002, 104(3), 221-230.
[http://dx.doi.org/10.1006/clim.2002.5241 ] [PMID: 12217331]
[29]
Silva, P.; Justicia, A.; Regueiro, A.; Fariña, S.; Couselo, J.M.; Loidi, L. Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene. Genes Immun., 2017, 18(3), 197-199.
[http://dx.doi.org/10.1038/gene.2017.14 ] [PMID: 28769069]
[30]
Cronin, F.E.; Jiang, M.; Abbas, A.K.; Grupp, S.A. Role of mu heavy chain in B cell development. I. Blocked B cell maturation but complete allelic exclusion in the absence of Ig alpha/beta. J. Immunol., 1998, 161(1), 252-259.
[PMID: 9647231]
[31]
Yazdani, R.; Abolhassani, H.; Kiaee, F.; Habibi, S.; Azizi, G.; Tavakol, M.; Chavoshzadeh, Z.; Mahdaviani, S.A.; Momen, T.; Gharagozlou, M.; Movahedi, M.; Hamidieh, A.A.; Behniafard, N.; Nabavi, M.; Bemanian, M.H.; Arshi, S.; Molatefi, R.; Sherkat, R.; Shirkani, A.; Amin, R.; Aleyasin, S.; Faridhosseini, R.; Jabbari-Azad, F.; Mohammadzadeh, I.; Ghaffari, J.; Shafiei, A.; Kalantari, A.; Mansouri, M.; Mesdaghi, M.; Babaie, D.; Ahanchian, H.; Khoshkhui, M.; Soheili, H.; Eslamian, M.H.; Cheraghi, T.; Dabbaghzadeh, A.; Tavassoli, M.; Kalmarzi, R.N.; Mortazavi, S.H.; Kashef, S.; Esmaeilzadeh, H.; Tafaroji, J.; Khalili, A.; Zandieh, F.; Sadeghi-Shabestari, M.; Darougar, S.; Behmanesh, F.; Akbari, H.; Zandkarimi, M.; Abolnezhadian, F.; Fayezi, A.; Moghtaderi, M.; Ahmadiafshar, A.; Shakerian, B.; Sajedi, V.; Taghvaei, B.; Safari, M.; Heidarzadeh, M.; Ghalebaghi, B.; Fathi, S.M.; Darabi, B.; Bazregari, S.; Bazargan, N.; Fallahpour, M.; Khayatzadeh, A.; Javahertrash, N.; Bashardoust, B.; Zamani, M.; Mohsenzadeh, A.; Ebrahimi, S.; Sharafian, S.; Vosughimotlagh, A.; Tafakoridelbari, M.; Rahim, M.; Ashournia, P.; Razaghian, A.; Rezaei, A.; Samavat, A.; Mamishi, S.; Khazaei, H.A.; Mohammadi, J.; Negahdari, B.; Parvaneh, N.; Rezaei, N.; Lougaris, V.; Giliani, S.; Plebani, A.; Ochs, H.D.; Hammarström, L.; Aghamohammadi, A. Comparison of common monogenic defects in a large predominantly antibody deficiency cohort. J. Allergy Clin. Immunol. Pract., 2019, 7(3), 864-878.e9.
[http://dx.doi.org/10.1016/j.jaip.2018.09.004 ] [PMID: 30240888]
[32]
van Zelm, M.C.; Geertsema, C.; Nieuwenhuis, N.; de Ridder, D.; Conley, M.E.; Schiff, C.; Tezcan, I.; Bernatowska, E.; Hartwig, N.G.; Sanders, E.A.; Litzman, J.; Kondratenko, I.; van Dongen, J.J.; van der Burg, M. Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am. J. Hum. Genet., 2008, 82(2), 320-332.
[http://dx.doi.org/10.1016/j.ajhg.2007.10.011 ] [PMID: 18252213]
[33]
Gemayel, K.T.; Litman, G.W.; Sriaroon, P. Autosomal recessive agammaglobulinemia associated with an IGLL1 gene missense mutation. Ann. Allergy Asthma Immunol., 2016, 117(4), 439-441.
[http://dx.doi.org/10.1016/j.anai.2016.07.038 ] [PMID: 27576013]
[34]
Mårtensson, A.; Xie, X.Q.; Persson, C.; Holm, M.; Grundström, T.; Mårtensson, I.L. PEBP2 and c-myb sites crucial for lambda5 core enhancer activity in pre-B cells. Eur. J. Immunol., 2001, 31(11), 3165-3174.
[http://dx.doi.org/10.1002/1521-4141(200111)31:11<3165:AID-IMMU3165>3.0.CO;2-N ] [PMID: 11745333]
[35]
Moens, L.N.; Falk-Sörqvist, E.; Asplund, A.C.; Bernatowska, E.; Smith, C.I.; Nilsson, M. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS One, 2014, 9(12)e114901
[http://dx.doi.org/10.1371/journal.pone.0114901 ] [PMID: 25502423]
[36]
Ohnishi, K.; Melchers, F. The nonimmunoglobulin portion of lambda5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol., 2003, 4(9), 849-856.
[http://dx.doi.org/10.1038/ni959 ] [PMID: 12897780]
[37]
Chiu, C.W.; Dalton, M.; Ishiai, M.; Kurosaki, T.; Chan, A.C. BLNK: molecular scaffolding through ‘cis’-mediated organization of signaling proteins. EMBO J., 2002, 21(23), 6461-6472.
[http://dx.doi.org/10.1093/emboj/cdf658 ] [PMID: 12456653]
[38]
Imamura, Y.; Oda, A.; Katahira, T.; Bundo, K.; Pike, K.A.; Ratcliffe, M.J.; Kitamura, D. BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation. J. Biol. Chem., 2009, 284(15), 9804-9813.
[http://dx.doi.org/10.1074/jbc.M809051200 ] [PMID: 19218240]
[39]
Taguchi, T.; Kiyokawa, N.; Takenouch, H.; Matsui, J.; Tang, W.R.; Nakajima, H.; Suzuki, K.; Shiozawa, Y.; Saito, M.; Katagiri, Y.U.; Takahashi, T.; Karasuyama, H.; Matsuo, Y.; Okita, H.; Fujimoto, J. Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells. Immunology, 2004, 112(4), 575-582.
[http://dx.doi.org/10.1111/j.1365-2567.2004.01918.x ] [PMID: 15270728]
[40]
Miyazaki, A.; Yogosawa, S.; Murakami, A.; Kitamura, D. Identification of CMTM7 as a transmembrane linker of BLNK and the B-cell receptor. PLoS One, 2012, 7(2)e31829
[http://dx.doi.org/10.1371/journal.pone.0031829 ] [PMID: 22363743]
[41]
Vendel, A.C. Calemine-Fenaux, J.; Izrael-Tomasevic, A.; Chauhan, V.; Arnott, D.; Eaton, D.L.B. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J. Immunol., 2009, 182(3), 1509-1517.
[http://dx.doi.org/10.4049/jimmunol.182.3.1509 ] [PMID: 19155498]
[42]
Abolhassani, H.; Aghamohammadi, A.; Fang, M.; Rezaei, N.; Jiang, C.; Liu, X.; Pan-Hammarström, Q.; Hammarström, L. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet. Med., 2019, 21(1), 243-251.
[http://dx.doi.org/10.1038/s41436-018-0012-x ] [PMID: 29921932]
[43]
Lagresle-Peyrou, C.; Millili, M.; Luce, S.; Boned, A.; Sadek, H.; Rouiller, J.; Frange, P.; Cros, G.; Cavazzana, M.; André-Schmutz, I.; Schiff, C. The BLNK adaptor protein has a nonredundant role in human B-cell differentiation. J. Allergy Clin. Immunol., 2014, 134(1), 145-154.
[http://dx.doi.org/10.1016/j.jaci.2013.12.1083 ] [PMID: 24582315]
[44]
NaserEddin A.; Shamriz, O.; Keller, B.; Alzyoud, R.M.; Unger, S.; Fisch, P.; Prus, E.; Berkun, Y.; Averbuch, D.; Shaag, A.; Wahadneh, A.M.; Conley, M.E.; Warnatz, K.; Elpeleg, O.; Stepensky, P. Enteroviral infection in a patient with BLNK adaptor protein deficiency. J. Clin. Immunol., 2015, 35(4), 356-360.
[http://dx.doi.org/10.1007/s10875-015-0164-2 ] [PMID: 25893637]
[45]
Tsukada, S.; Baba, Y.; Watanabe, D. Btk and BLNK in B cell development. Adv. Immunol., 2001, 77, 123-162.
[http://dx.doi.org/10.1016/S0065-2776(01)77016-2 ] [PMID: 11293115]
[46]
Hashimoto, S.; Chiorazzi, N.; Gregersen, P.K. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol. Immunol., 1995, 32(9), 651-659.
[http://dx.doi.org/10.1016/0161-5890(95)00023-8 ] [PMID: 7643857]
[47]
Benlagha, K.; Guglielmi, P.; Cooper, M.D.; Lassoued, K. Modifications of Igalpha and Igbeta expression as a function of B lineage differentiation. J. Biol. Chem., 1999, 274(27), 19389-19396.
[http://dx.doi.org/10.1074/jbc.274.27.19389 ] [PMID: 10383452]
[48]
Ben-Ali, M.; Kechout, N.; Mekki, N.; Yang, J.; Chan, K.W.; Barakat, A.; Aadam, Z.; Gamara, J.; Gargouri, L.; Largueche, B. BelHadj-Hmida, N.; Nedri, A.; Ameur, H.B.; Mellouli, F.; Boukari, R.; Bejaoui, M.; Bousfiha, A.; Ben-Mustapha, I.; Lau, Y.L.; Barbouche, M.R. Genetic approaches for definitive diagnosis of Agammaglobulinemia in consanguineous families. J. Clin. Immunol., 2020, 40(1), 96-104.
[http://dx.doi.org/10.1007/s10875-019-00706-4 ] [PMID: 31696364]
[49]
Langereis, J.D.; Henriet, S.S.; Kuipers, S.; Weemaes, C.M.R.; van der Burg, M.; de Jonge, M.I.; van der Flier, M. IgM augments complement bactericidal activity with serum from a patient with a novel CD79a mutation. J. Clin. Immunol., 2018, 38(2), 185-192.
[http://dx.doi.org/10.1007/s10875-017-0474-7 ] [PMID: 29335801]
[50]
Lougaris, V.; Vitali, M.; Baronio, M.; Moratto, D.; Tampella, G.; Biasini, A.; Badolato, R.; Plebani, A. Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation. J. Clin. Immunol., 2014, 34(4), 425-427.
[http://dx.doi.org/10.1007/s10875-014-0033-4 ] [PMID: 24722855]
[51]
Vanhaesebroeck, B.; Stephens, L.; Hawkins, P. PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol., 2012, 13(3), 195-203.
[http://dx.doi.org/10.1038/nrm3290 ] [PMID: 22358332]
[52]
Omori, S.A.; Rickert, R.C. Phosphatidylinositol 3-kinase (PI3K) signaling and regulation of the antibody response. Cell Cycle, 2007, 6(4), 397-402.
[http://dx.doi.org/10.4161/cc.6.4.3837 ] [PMID: 17312395]
[53]
Beck, K.; Peak, M.M.; Ota, T.; Nemazee, D.; Murre, C. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med., 2009, 206(10), 2271-2284.
[http://dx.doi.org/10.1084/jem.20090756 ] [PMID: 19752184]
[54]
Qureshi, S.; Sheikh, M.D.A.; Qamar, F.N. Autosomal Recessive Agammaglobulinemia - first case with a novel TCF3 mutation from Pakistan. Clin. Immunol., 2019, 198, 100-101.
[http://dx.doi.org/10.1016/j.clim.2018.07.016 ] [PMID: 30063982]
[55]
Ben-Ali, M.; Yang, J.; Chan, K.W.; Ben-Mustapha, I.; Mekki, N.; Benabdesselem, C.; Mellouli, F.; Bejaoui, M.; Yang, W.; Aissaoui, L.; Lau, Y.L.; Barbouche, M.R. Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia. J. Allergy Clin. Immunol., 2017, 140(4), 1191-1194.e4.
[http://dx.doi.org/10.1016/j.jaci.2017.04.037 ] [PMID: 28532655]
[56]
Conley, M.E. Genes required for B cell development. J. Clin. Invest., 2003, 112(11), 1636-1638.
[http://dx.doi.org/10.1172/JCI20408 ] [PMID: 14660738]
[57]
Kubota, K.; Kim, J.Y.; Sawada, A.; Tokimasa, S.; Fujisaki, H.; Matsuda-Hashii, Y.; Ozono, K.; Hara, J. LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins. FEBS Lett., 2004, 564(1-2), 147-152.
[http://dx.doi.org/10.1016/S0014-5793(04)00332-1 ] [PMID: 15094057]
[58]
Austin, C.A.; Marsh, K.L. Eukaryotic DNA topoisomerase II beta. BioEssays, 1998, 20(3), 215-226.
[http://dx.doi.org/10.1002/(SICI)1521-1878(199803)20:3<215:AID-BIES5>3.0.CO;2-Q ] [PMID: 9631649]
[59]
Hoffman, H.M.; Bastian, J.F.; Bird, L.M. Humoral immunodeficiency with facial dysmorphology and limb anomalies: a new syndrome. Clin. Dysmorphol., 2001, 10(1), 1-8.
[http://dx.doi.org/10.1097/00019605-200101000-00001 ] [PMID: 11152140]
[60]
Feske, S.; Gwack, Y.; Prakriya, M.; Srikanth, S.; Puppel, S.H.; Tanasa, B.; Hogan, P.G.; Lewis, R.S.; Daly, M.; Rao, A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature, 2006, 441(7090), 179-185.
[http://dx.doi.org/10.1038/nature04702 ] [PMID: 16582901]
[61]
Li, F.Y.; Chaigne-Delalande, B.; Kanellopoulou, C.; Davis, J.C.; Matthews, H.F.; Douek, D.C.; Cohen, J.I.; Uzel, G.; Su, H.C.; Lenardo, M.J. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature, 2011, 475(7357), 471-476.
[http://dx.doi.org/10.1038/nature10246 ] [PMID: 21796205]
[62]
Kambe, T.; Hashimoto, A.; Fujimoto, S. Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell. Mol. Life Sci., 2014, 71(17), 3281-3295.
[http://dx.doi.org/10.1007/s00018-014-1617-0 ] [PMID: 24710731]
[63]
Fraker, P.J.; King, L.E. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr., 2004, 24, 277-298.
[http://dx.doi.org/10.1146/annurev.nutr.24.012003.132454 ] [PMID: 15189122]
[64]
Küry, S.; Dréno, B.; Bézieau, S.; Giraudet, S.; Kharfi, M.; Kamoun, R.; Moisan, J.P. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat. Genet., 2002, 31(3), 239-240.
[http://dx.doi.org/10.1038/ng913 ] [PMID: 12068297]
[65]
Abolhassani, H.; Vitali, M.; Lougaris, V.; Giliani, S.; Parvaneh, N.; Parvaneh, L.; Mirminachi, B.; Cheraghi, T.; Khazaei, H.; Mahdaviani, S.A.; Kiaei, F.; Tavakolinia, N.; Mohammadi, J.; Negahdari, B.; Rezaei, N.; Hammarstrom, L.; Plebani, A.; Aghamohammadi, A. Cohort of Iranian Patients with congenital Agammaglobulinemia: mutation analysis and novel gene defects. Expert Rev. Clin. Immunol., 2016, 12(4), 479-486.
[http://dx.doi.org/10.1586/1744666X.2016.1139451 ] [PMID: 26910880]
[66]
Lederman, H.M.; Winkelstein, J.A. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore), 1985, 64(3), 145-156.
[http://dx.doi.org/10.1097/00005792-198505000-00001 ] [PMID: 2581110]
[67]
Abolhassani, H.; Hirbod-Mobarakeh, A.; Shahinpour, S.; Panahi, M.; Mohammadinejad, P.; Mirminachi, B.; Shakari, M.S.; Samavat, B.; Aghamohammadi, A. Mortality and morbidity in patients with X-linked agammaglobulinaemia. Allergol. Immunopathol. (Madr.), 2015, 43(1), 62-66.
[http://dx.doi.org/10.1016/j.aller.2013.09.013 ] [PMID: 24485939]
[68]
Bagheri, Y.; Vosughi, A.; Azizi, G.; Yazdani, R.; Kiaee, F.; Hafezi, N.; Alimorad, S.; Khoshmirsafa, M.; Seif, F.; Hassanpour, G.; Abolhassani, H.; Aghamohammadi, A. Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients. Immunol. Lett., 2019, 210, 55-62.
[http://dx.doi.org/10.1016/j.imlet.2019.05.001 ] [PMID: 31059734]
[69]
Yazdani, R.; Abolhassani, H.; Asgardoon, M.H.; Shaghaghi, M.; Modaresi, M.; Azizi, G.; Aghamohammadi, A. Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders. J. Investig. Allergol. Clin. Immunol., 2017, 27(4), 213-224.
[http://dx.doi.org/10.18176/jiaci.0166 ] [PMID: 28731410]
[70]
Benninger, M.S.; Ferguson, B.J.; Hadley, J.A.; Hamilos, D.L.; Jacobs, M.; Kennedy, D.W.; Lanza, D.C.; Marple, B.F.; Osguthorpe, J.D.; Stankiewicz, J.A.; Anon, J.; Denneny, J.; Emanuel, I.; Levine, H. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol. Head Neck Surg., 2003, 129(3)(Suppl.), S1-S32.
[http://dx.doi.org/10.1053/hn.2003.v128.amhn0312811 ] [PMID: 12958561]
[71]
Arkwright, P.D.; Gennery, A.R. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann. N. Y. Acad. Sci., 2011, 1238, 7-14.
[http://dx.doi.org/10.1111/j.1749-6632.2011.06206.x ] [PMID: 22129048]
[72]
Yarmohammadi, H.; Estrella, L.; Doucette, J.; Cunningham-Rundles, C. Recognizing primary immune deficiency in clinical practice. Clin. Vaccine Immunol., 2006, 13(3), 329-332.
[http://dx.doi.org/10.1128/CVI.13.3.329-332.2006 ] [PMID: 16522773]
[73]
Bernatowska, E.; Mikołuć, B.; Krzeski, A.; Piatosa, B.; Gromek, I. Chronic rhinosinusitis in primary antibody immunodeficient patients. Int. J. Pediatr. Otorhinolaryngol., 2006, 70(9), 1587-1592.
[http://dx.doi.org/10.1016/j.ijporl.2006.04.013 ] [PMID: 16774791]
[74]
Conley, M.E.; Howard, V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J. Pediatr., 2002, 141(4), 566-571.
[http://dx.doi.org/10.1067/mpd.2002.127711 ] [PMID: 12378199]
[75]
Leibovitz, E.; Broides, A.; Greenberg, D.; Newman, N. Current management of pediatric acute otitis media. Expert Rev. Anti Infect. Ther., 2010, 8(2), 151-161.
[http://dx.doi.org/10.1586/eri.09.112 ] [PMID: 20109045]
[76]
Owayed, A.; Al-Herz, W. Sinopulmonary complications in subjects with primary immunodeficiency. Respir. Care, 2016, 61(8), 1067-1072.
[http://dx.doi.org/10.4187/respcare.04479 ] [PMID: 26957648]
[77]
Winkelstein, J.A.; Marino, M.C.; Lederman, H.M.; Jones, S.M.; Sullivan, K.; Burks, A.W.; Conley, M.E.; Cunningham-Rundles, C.; Ochs, H.D. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore), 2006, 85(4), 193-202.
[http://dx.doi.org/10.1097/01.md.0000229482.27398.ad ] [PMID: 16862044]
[78]
Moin, M.; Aghamohammadi, A.; Farhoudi, A.; Pourpak, Z.; Rezaei, N.; Movahedi, M.; Gharagozlou, M.; Ghazi, B.M.; Zahed, A.; Abolmaali, K.; Mahmoudi, M.; Emami, L.; Bashashati, M. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol. Invest., 2004, 33(1), 81-93.
[http://dx.doi.org/10.1081/IMM-120027687 ] [PMID: 15015835]
[79]
Kinkade, S.; Long, N.A. Acute bronchitis. Am. Fam. Physician, 2016, 94(7), 560-565.
[PMID: 27929206]
[80]
Pasteur, M.C.; Helliwell, S.M.; Houghton, S.J.; Webb, S.C.; Foweraker, J.E.; Coulden, R.A.; Flower, C.D.; Bilton, D.; Keogan, M.T. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med., 2000, 162(4 Pt 1), 1277-1284.
[http://dx.doi.org/10.1164/ajrccm.162.4.9906120 ] [PMID: 11029331]
[81]
Shoemark, A.; Ozerovitch, L.; Wilson, R. Aetiology in adult patients with bronchiectasis. Respir. Med., 2007, 101(6), 1163-1170.
[http://dx.doi.org/10.1016/j.rmed.2006.11.008 ] [PMID: 17223027]
[82]
Gharagozlou, M.; Ebrahimi, F.A.; Farhoudi, A.; Aghamohammadi, A.; Bemanian, M.H.; Chavoshzadeh, Z.; Heidarzadeh, M.; Mehdizadeh, M.; Moin, M.; Movahedi, M.; Nabavi, M.; Pourpak, Z.; Rezaei, N. Pulmonary complications in primary hypogammaglobulinemia: a survey by high resolution CT scan. Monaldi Arch. Chest Dis., 2006, 65(2), 69-74.
[PMID: 16913576]
[83]
Notarangelo, L.D.; Plebani, A.; Mazzolari, E.; Soresina, A.; Bondioni, M.P. Genetic causes of bronchiectasis: primary immune deficiencies and the lung. Respiration, 2007, 74(3), 264-275.
[http://dx.doi.org/10.1159/000101784]
[84]
Stead, A.; Douglas, J.G.; Broadfoot, C.J.; Kaminski, E.R.; Herriot, R. Humoral immunity and bronchiectasis. Clin. Exp. Immunol., 2002, 130(2), 325-330.
[http://dx.doi.org/10.1046/j.1365-2249.2002.01974.x ] [PMID: 12390323]
[85]
Tabatabaie, P.; Aghamohammadi, A.; Mamishi, S.; Isaeian, A.; Heidari, G.; Abdollahzade, S.; Pirouzi, P.; Rezaei, N.; Heidarnazhad, H.; Mirsaeid Ghazi, B.; Yeganeh, M.; Cheraghi, T.; Abolhasani, H.; Saghafi, S.; Alizadeh, H.; Anaraki, M.R. Evaluation of humoral immune function in patients with bronchiectasis. Iran. J. Allergy Asthma Immunol., 2008, 7(2), 69-77.
[PMID: 18552408]
[86]
Li, A.M.; Sonnappa, S.; Lex, C.; Wong, E.; Zacharasiewicz, A.; Bush, A.; Jaffe, A. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur. Respir. J., 2005, 26(1), 8-14.
[http://dx.doi.org/10.1183/09031936.05.00127704 ] [PMID: 15994383]
[87]
Lieberman-Maran, L.; Orzano, I.M.; Passero, M.A.; Lally, E.V. Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature--implications for management with biologic response modifiers. Semin. Arthritis Rheum., 2006, 35(6), 379-387.
[http://dx.doi.org/10.1016/j.semarthrit.2006.02.003 ] [PMID: 16765715]
[88]
Rodrigo, M.J.; Miravitlles, M.; Cruz, M.J.; de Gracia, J.; Vendrell, M.; Pascual, C.; Morell, F. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria. Clin. Diagn. Lab. Immunol., 1997, 4(2), 168-172.
[http://dx.doi.org/10.1128/CDLI.4.2.168-172.1997 ] [PMID: 9067650]
[89]
Aghamohammadi, A.; Allahverdi, A.; Abolhassani, H.; Moazzami, K.; Alizadeh, H.; Gharagozlou, M.; Kalantari, N.; Sajedi, V.; Shafiei, A.; Parvaneh, N.; Mohammadpour, M.; Karimi, N.; Sadaghiani, M.S.; Rezaei, N. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology, 2010, 15(2), 289-295.
[http://dx.doi.org/10.1111/j.1440-1843.2009.01679.x ] [PMID: 20051045]
[90]
Agarwal, S; Mayer, L Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.,, 2013, 11(9), 1050-1063.
[http://dx.doi.org/10.1016/j.cgh.2013.02.024]
[91]
Hernandez-Trujillo, V.P.; Scalchunes, C.; Cunningham-Rundles, C.; Ochs, H.D.; Bonilla, F.A.; Paris, K.; Yel, L.; Sullivan, K.E. Autoimmunity and inflammation in X-linked agammaglobulinemia. J. Clin. Immunol., 2014, 34(6), 627-632.
[http://dx.doi.org/10.1007/s10875-014-0056-x ] [PMID: 24909997]
[92]
Barmettler, S.; Otani, I.M.; Minhas, J.; Abraham, R.S.; Chang, Y.; Dorsey, M.J.; Ballas, Z.K.; Bonilla, F.A.; Ochs, H.D.; Walter, J.E. Gastrointestinal manifestations in X-linked agammaglobulinemia. J. Clin. Immunol., 2017, 37(3), 287-294.
[http://dx.doi.org/10.1007/s10875-017-0374-x ] [PMID: 28236219]
[93]
Halliday, E.; Winkelstein, J.; Webster, A.D. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J. Infect., 2003, 46(1), 1-8.
[http://dx.doi.org/10.1053/jinf.2002.1066 ] [PMID: 12504601]
[94]
Rudge, P.; Webster, A.D.; Revesz, T.; Warner, T.; Espanol, T.; Cunningham-Rundles, C.; Hyman, N. Encephalomyelitis in primary hypogammaglobulinaemia. Brain, 1996, 119(Pt 1), 1-15.
[http://dx.doi.org/10.1093/brain/119.1.1 ] [PMID: 8624673]
[95]
Sarpong, S.; Skolnick, H.S.; Ochs, H.D.; Futatani, T.; Winkelstein, J.A. Survival of wild polio by a patient with XLA. Ann. Allergy Asthma Immunol., 2002, 88(1), 59-60.
[http://dx.doi.org/10.1016/S1081-1206(10)63593-4 ] [PMID: 11814279]
[96]
Ng, Y.S.; Wardemann, H.; Chelnis, J.; Cunningham-Rundles, C.; Meffre, E. Bruton’s tyrosine kinase is essential for human B cell tolerance. J. Exp. Med., 2004, 200(7), 927-934.
[http://dx.doi.org/10.1084/jem.20040920 ] [PMID: 15466623]
[97]
Samuels, J.; Ng, Y.S.; Coupillaud, C.; Paget, D.; Meffre, E. Human B cell tolerance and its failure in rheumatoid arthritis. Ann. N. Y. Acad. Sci., 2005, 1062, 116-126.
[http://dx.doi.org/10.1196/annals.1358.014 ] [PMID: 16461794]
[98]
Behniafard, N.; Aghamohammadi, A.; Abolhassani, H.; Pourjabbar, S.; Sabouni, F.; Rezaei, N. Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature. Expert Rev. Clin. Immunol., 2012, 8(2), 155-159.
[http://dx.doi.org/10.1586/eci.11.94 ] [PMID: 22288453]
[99]
Jacobs, Z.D.; Guajardo, J.R.; Anderson, K.M. XLA-associated neutropenia treatment: a case report and review of the literature. J. Pediatr. Hematol. Oncol., 2008, 30(8), 631-634.
[http://dx.doi.org/10.1097/MPH.0b013e3181758947 ] [PMID: 18799945]
[100]
Azizi, G.; Ahmadi, M.; Abolhassani, H.; Yazdani, R.; Mohammadi, H.; Mirshafiey, A.; Rezaei, N.; Aghamohammadi, A. Autoimmunity in primary antibody deficiencies. Int. Arch. Allergy Immunol., 2016, 171(3-4), 180-193.
[http://dx.doi.org/10.1159/000453263 ] [PMID: 28013299]
[101]
Sag, A.T.; Saka, E.; Ozgur, T.T.; Sanal, O.; Ayvaz, D.C.; Elibol, B. Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy. Cogn. Behav. Neurol., 2014, 27(3), 155-159.
[http://dx.doi.org/10.1097/WNN.0000000000000037] [PMID: 25237746]
[102]
Tuzankina, I.; Kobeleva, Y.; Kiseleva, N.; Bolkov, M.; Reuter, G.; Maródi, L. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease. Allergy, 2011, 66(12), 1617-1618.
[http://dx.doi.org/10.1111/j.1398-9995.2011.02718.x ] [PMID: 21951217]
[103]
Corneth, O.B.J.; Klein Wolterink, R.G.J.; Hendriks, R.W. BTK Signaling in B cell differentiation and autoimmunity. Curr. Top. Microbiol. Immunol., 2016, 393, 67-105.
[http://dx.doi.org/10.1007/82_2015_478 ] [PMID: 26341110]
[104]
Lavilla, P.; Gil, A.; Rodríguez, M.C.; Dupla, M.L.; Pintado, V.; Fontán, G. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer, 1993, 72(5), 1528-1531.
[http://dx.doi.org/10.1002/1097-0142(19930901)72:5<1528:AID-CNCR2820720506>3.0.CO;2-V ] [PMID: 8348486]
[105]
van der Meer, J.W.; Weening, R.S.; Schellekens, P.T.; van Munster, I.P.; Nagengast, F.M. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet, 1993, 341(8858), 1439-1440.
[http://dx.doi.org/10.1016/0140-6736(93)90883-I ] [PMID: 8099142]
[106]
Hermaszewski, R.A.; Webster, A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med., 1993, 86(1), 31-42.
[PMID: 8438047]
[107]
Spector, B.D.; Perry, G.S., III; Kersey, J.H. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry. Clin. Immunol. Immunopathol., 1978, 11(1), 12-29.
[http://dx.doi.org/10.1016/0090-1229(78)90200-3 ] [PMID: 699386]
[108]
Gompels, M.M.; Hodges, E.; Lock, R.J.; Angus, B.; White, H.; Larkin, A.; Chapel, H.M.; Spickett, G.P.; Misbah, S.A.; Smith, J.L. Associated Study Group Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin. Exp. Immunol., 2003, 134(2), 314-320.
[http://dx.doi.org/10.1046/j.1365-2249.2003.02253.x ] [PMID: 14616793]
[109]
Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420(6917), 860-867.
[http://dx.doi.org/10.1038/nature01322 ] [PMID: 12490959]
[110]
Rhodes, J.M.; Campbell, B.J. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol. Med., 2002, 8(1), 10-16.
[http://dx.doi.org/10.1016/S1471-4914(01)02194-3 ] [PMID: 11796261]
[111]
Bachmeyer, C.; Monge, M.; Cazier, A.; Le Deist, F.; de Saint Basile, G.; Durandy, A.; Fischer, A.; Mougeot-Martin, M. Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia. Eur. J. Gastroenterol. Hepatol., 2000, 12(9), 1033-1035.
[http://dx.doi.org/10.1097/00042737-200012090-00013 ] [PMID: 11007143]
[112]
Lackmann, G.M.; Wahn, V.; Poremba, C.; Niehues, T. A teenager with X-linked agammaglobulinemia and vitamin B12 deficiency anemia. J. Pediatr. Gastroenterol. Nutr., 2005, 41(3), 360-362.
[http://dx.doi.org/10.1097/01.MPG.0000153003.59448.36 ] [PMID: 16131996]
[113]
Jumaa, H.; Hendriks, R.W.; Reth, M. B cell signaling and tumorigenesis. Annu. Rev. Immunol., 2005, 23, 415-445.
[http://dx.doi.org/10.1146/annurev.immunol.23.021704.115606 ] [PMID: 15771577]
[114]
Roifman, C.M.; Rao, C.P.; Lederman, H.M.; Lavi, S.; Quinn, P.; Gelfand, E.W. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am. J. Med., 1986, 80(4), 590-594.
[http://dx.doi.org/10.1016/0002-9343(86)90812-0 ] [PMID: 3963038]
[115]
Ipp, M.M.; Gelfand, E.W. Antibody deficiency and alopecia. J. Pediatr., 1976, 89(5), 728-731.
[http://dx.doi.org/10.1016/S0022-3476(76)80791-3 ] [PMID: 978318]
[116]
Guioli, S.; Arveiler, B.; Bardoni, B.; Notarangelo, L.D.; Panina, P.; Duse, M.; Ugazio, A.; Oberlé, I.; de Saint Basile, G.; Mandel, J.L. Close linkage of probe p212 (DXS178) to X-linked agammaglobulinemia. Hum. Genet., 1989, 84(1), 19-21.
[http://dx.doi.org/10.1007/BF00210664 ] [PMID: 2575070]
[117]
Buckley, R.H.; Rowlands, D.T. Jr Agammaglobulinemia, neutropenia, fever, and abdominal pain. J. Allergy Clin. Immunol., 1973, 51(5), 308-318.
[http://dx.doi.org/10.1016/0091-6749(73)90133-4 ] [PMID: 4697357]
[118]
Dubois, R.S.; Roy, C.C.; Fulginiti, V.A.; Merrill, D.A.; Murray, R.L. Disaccharidase deficiency in children with immunologic deficits. J. Pediatr., 1970, 76(3), 377-385.
[http://dx.doi.org/10.1016/S0022-3476(70)80476-0 ] [PMID: 4189883]
[119]
Norman, M.E.; Hansell, J.R.; Holtzapple, P.G.; Parks, J.S.; Waldmann, T.A. Malabsorption and protein-losing enteropathy in a child with X-linked agammaglobulinemia. Clin. Immunol. Immunopathol., 1975, 4(2), 157-164.
[http://dx.doi.org/10.1016/0090-1229(75)90051-3 ] [PMID: 49233]
[120]
Seidel, M.G.; Kindle, G.; Gathmann, B.; Quinti, I.; Buckland, M.; van Montfrans, J.; Scheible, R.; Rusch, S.; Gasteiger, L.M.; Grimbacher, B.; Mahlaoui, N.; Ehl, S. ESID Registry Working Party and collaborators. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J. Allergy Clin. Immunol. Pract., 2019, 7(6), 1763-1770.
[http://dx.doi.org/10.1016/j.jaip.2019.02.004 ] [PMID: 30776527]
[121]
Futatani, T.; Miyawaki, T.; Tsukada, S.; Hashimoto, S.; Kunikata, T.; Arai, S.; Kurimoto, M.; Niida, Y.; Matsuoka, H.; Sakiyama, Y.; Iwata, T.; Tsuchiya, S.; Tatsuzawa, O.; Yoshizaki, K.; Kishimoto, T. Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood, 1998, 91(2), 595-602.
[PMID: 9427714]
[122]
Borte, S.; von Döbeln, U.; Fasth, A.; Wang, N.; Janzi, M.; Winiarski, J.; Sack, U.; Pan-Hammarström, Q.; Borte, M.; Hammarström, L. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood, 2012, 119(11), 2552-2555.
[http://dx.doi.org/10.1182/blood-2011-08-371021 ] [PMID: 22130802]
[123]
Bonagura, V.R.; Marchlewski, R.; Cox, A.; Rosenthal, D.W. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J. Allergy Clin. Immunol., 2008, 122(1), 210-212.
[http://dx.doi.org/10.1016/j.jaci.2008.04.044 ] [PMID: 18602574]
[124]
Shillitoe, B.; Gennery, A. X-linked agammaglobulinaemia: Outcomes in the modern era. Clin. Immunol., 2017, 183, 54-62.
[http://dx.doi.org/10.1016/j.clim.2017.07.008 ] [PMID: 28729230]
[125]
Howard, V.; Myers, L.A.; Williams, D.A.; Wheeler, G.; Turner, E.V.; Cunningham, J.M.; Conley, M.E. Stem cell transplants for patients with X-linked agammaglobulinemia. Clin. Immunol., 2003, 107(2), 98-102.
[http://dx.doi.org/10.1016/S1521-6616(03)00045-7 ] [PMID: 12763478]
[126]
Abu-Arja, R.F.; Chernin, L.R.; Abusin, G.; Auletta, J.; Cabral, L.; Egler, R.; Ochs, H.D.; Torgerson, T.R.; Lopez-Guisa, J.; Hostoffer, R.W.; Tcheurekdjian, H.; Cooke, K.R. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia. Pediatr. Blood Cancer, 2015, 62(9), 1674-1676.
[http://dx.doi.org/10.1002/pbc.25554 ] [PMID: 25900577]
[127]
Aghamohammadi, A.; Montazeri, A.; Abolhassani, H.; Saroukhani, S.; Pourjabbar, S.; Tavassoli, M.; Darabi, B.; Imanzadeh, A.; Parvaneh, N.; Rezaei, N. Health-related quality of life in primary antibody deficiency. Iran. J. Allergy Asthma Immunol., 2011, 10(1), 47-51.
[PMID: 21358015]
[128]
Soresina, A.; Nacinovich, R.; Bomba, M.; Cassani, M.; Molinaro, A.; Sciotto, A.; Martino, S.; Cardinale, F.; De Mattia, D.; Putti, C.; Dellepiane, R.M.; Felici, L.; Parrinello, G.; Neri, F.; Plebani, A. Italian Network for Primary Immunodeficiencies. The quality of life of children and adolescents with X-linked agammaglobulinemia. J. Clin. Immunol., 2009, 29(4), 501-507.
[http://dx.doi.org/10.1007/s10875-008-9270-8 ]
[129]
Conley, M.E.; Rohrer, J.; Rapalus, L.; Boylin, E.C.; Minegishi, Y. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol. Rev., 2000, 178, 75-90.
[http://dx.doi.org/10.1034/j.1600-065X.2000.17809.x ] [PMID: 11213809]
[130]
Lindvall, J.M.; Blomberg, K.E.; Väliaho, J.; Vargas, L.; Heinonen, J.E.; Berglöf, A.; Mohamed, A.J.; Nore, B.F.; Vihinen, M.; Smith, C.I. Bruton’s tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev., 2005, 203, 200-215.
[http://dx.doi.org/10.1111/j.0105-2896.2005.00225.x ] [PMID: 15661031]
[131]
Väliaho, J.; Smith, C.I.; Vihinen, M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum. Mutat 2006, 27(12), 1209-1217.
[http://dx.doi.org/10.1002/humu.20410] [PMID: 16969761]

Rights & Permissions Print Cite
Article Metrics
21
2
© 2024 Bentham Science Publishers | Privacy Policy